SI
CLMT icon

SCP Investment’s Calumet Specialty Products CLMT Stock Holding History

SCP Investment’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,800
Closed -$317K – 34
2022
Q4 		$317K Buy
+18,800
New +$303K 0.31% 13

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bienville Capital Management New York $550M AUM 3.49% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCP Investment's CLMT Position: Q1 2023 in Review

SCP Investment sold out of Calumet Specialty Products (CLMT) in Q1 2023, closing a stake of 18,800 shares — an estimated $317K sold.

SCP Investment first reported a position in CLMT in Q4 2022 and held it in 1 quarter. The position peaked at $317K in Q4 2022. 70 funds tracked by Wall St. Rank hold CLMT as of Q1 2023.

  • SCP Investment reported no remaining Calumet Specialty Products position as of Q1 2023 after selling out during the quarter.
  • SCP Investment sold 18,800 Calumet Specialty Products shares in Q1 2023, an estimated $317K.
  • SCP Investment first reported a position in Calumet Specialty Products in Q4 2022 and held it in 1 quarter.
  • SCP Investment's Calumet Specialty Products position peaked at $317K in Q4 2022.
  • 70 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2023.

Based on SCP Investment's 13F filing for Q1 2023, filed 9 May 2023.